TCG Crossover is a science-driven investment firm focused on advancing disruptive medicines. The firm operates in the life sciences investment space, funding and guiding early- to late-stage pharmaceutical and biotech ventures with a mission to accelerate breakthrough therapies. Based on the information available, it emphasizes scientific rigor and portfolio development in the biopharma sector, and positions itself as a dedicated investor in breakthrough medicines. The organization is associated with its online presence and professional network, including a LinkedIn profile.